S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
OTCMKTS:SWTUY

SWEDISH ORPHAN/S News Headlines

$24.38
-0.29 (-1.18 %)
(As of 04/9/2019)
Add
Compare
Today's Range
$24.38
Now: $24.38
$24.38
50-Day Range
$24.38
MA: $24.38
$24.38
52-Week Range
$18.50
Now: $24.38
$31.96
Volume200 shs
Average Volume1,665 shs
Market Capitalization$6.64 billion
P/E Ratio48.76
Dividend YieldN/A
Beta1.81

Headlines

SWEDISH ORPHAN/S (OTCMKTS SWTUY) News Headlines Today

Source:
SourceHeadline
Harpoons (HARP) Multiple Myeloma Candidate Gets Orphan Drug TagHarpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag
nasdaq.com - January 14 at 5:56 PM
Vitamins C and E Tied to Lower Risk for Parkinson’s DiseaseVitamins C and E Tied to Lower Risk for Parkinson’s Disease
nytimes.com - January 13 at 7:34 PM
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOsThe Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
benzinga.com - January 8 at 7:40 AM
Orphan diseases Market Global Size, Historical Analysis, Recent Trends, Opportunity Assessment, Future Scope and Potential of Industry upto 2022Orphan diseases Market Global Size, Historical Analysis, Recent Trends, Opportunity Assessment, Future Scope and Potential of Industry upto 2022
marketwatch.com - January 8 at 2:39 AM
RedHills (RDHL) RHB-204 Gets FDA Fast Track DesignationRedHill's (RDHL) RHB-204 Gets FDA Fast Track Designation
nasdaq.com - January 7 at 10:44 AM
Air pollution may contribute to Alzheimer’s and dementia risk – here’s what we’re learning from brain scansAir pollution may contribute to Alzheimer’s and dementia risk – here’s what we’re learning from brain scans
msn.com - January 5 at 9:24 AM
Cigars and Cigarillos Booming Segments; Investors Seeking Growth| Swedish Match , Trendsettah, Imperial BrandsCigars and Cigarillos Booming Segments; Investors Seeking Growth| Swedish Match , Trendsettah, Imperial Brands
marketwatch.com - January 4 at 6:21 PM
SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Trading Down 1.2%SWEDISH ORPHAN/S (OTCMKTS:SWTUY) Trading Down 1.2%
americanbankingnews.com - January 2 at 12:40 AM
1,400 orphans in S.F.: Devastating Spanish Flu didn’t spare the young1,400 orphans in S.F.: Devastating Spanish Flu didn’t spare the young
msn.com - December 23 at 12:18 AM
Here’s How AstraZeneca Says Covid-19 Could Accelerate Cancer Clinical TrialsHere’s How AstraZeneca Says Covid-19 Could Accelerate Cancer Clinical Trials
barrons.com - December 2 at 3:35 PM
Analysis: COVID-19 worsens Europes inequalities in yet another way - the fertility gapAnalysis: COVID-19 worsens Europe's inequalities in yet another way - the fertility gap
reuters.com - December 1 at 6:34 AM
Swedish Life Expectancy to Drop for First Time in Century Due to Covid-19Swedish Life Expectancy to Drop for First Time in Century Due to Covid-19
msn.com - November 25 at 3:54 PM
Global Non-oncology Biopharmaceuticals Market 2020 Research Study with Trends and Opportunities to 2026 - Impact of COVID-19Global Non-oncology Biopharmaceuticals Market 2020 Research Study with Trends and Opportunities to 2026 - Impact of COVID-19
marketwatch.com - November 24 at 1:22 AM
Roche’s Actemra Helps Critically Ill Covid Patients in TestRoche’s Actemra Helps Critically Ill Covid Patients in Test
bloomberg.com - November 19 at 2:24 PM
Dosing underway for Apellis, Sobis study of pegcetacoplan in muscle weaknessDosing underway for Apellis, Sobi's study of pegcetacoplan in muscle weakness
seekingalpha.com - November 19 at 9:23 AM
Selectas (SELB) Q3 Loss Narrower-Than Expected, Revenues BeatSelecta's (SELB) Q3 Loss Narrower-Than Expected, Revenues Beat
nasdaq.com - November 5 at 12:18 PM
Sobi shares fall 16% as Avatrombopag study fails to meet primary endpointSobi shares fall 16% as Avatrombopag study fails to meet primary endpoint
nasdaq.com - October 11 at 5:24 AM
Sobi shares fall 17% as Avatrombopag study fails to meet primary endpointSobi shares fall 17% as Avatrombopag study fails to meet primary endpoint
nasdaq.com - October 9 at 2:13 PM
Swedish Orphan Biovitrum AB Nam (B6E.SG)Swedish Orphan Biovitrum AB Nam (B6E.SG)
au.finance.yahoo.com - October 9 at 9:13 AM
Swedish Orphans avatrombopag flunks late-stage study in chemo-induced low blood plateletsSwedish Orphan's avatrombopag flunks late-stage study in chemo-induced low blood platelets
seekingalpha.com - October 9 at 9:13 AM
Orphan Diseases Market Insights Shared in Detailed Report 2020 to 2026Orphan Diseases Market Insights Shared in Detailed Report 2020 to 2026
marketwatch.com - October 2 at 5:34 PM
Belarus activist and U.S. civil rights lawyer among winners of ‘Alternative Nobel’Belarus activist and U.S. civil rights lawyer among winners of ‘Alternative Nobel’
latimes.com - October 1 at 5:20 AM
HPV vaccine significantly lowers risk of cervical cancer, large study findsHPV vaccine significantly lowers risk of cervical cancer, large study finds
nbcnews.com - September 30 at 5:35 PM
Selectas SEL-212 misses primary endpoint in mid-stage gout study, shares fall 41%Selecta's SEL-212 misses primary endpoint in mid-stage gout study, shares fall 41%
seekingalpha.com - September 30 at 5:35 PM
AbbVie Elezanumab Gets FDAs Fast Track and Orphan Drug TagsAbbVie Elezanumab Gets FDA's Fast Track and Orphan Drug Tags
nasdaq.com - September 29 at 2:40 PM
Open Orphan wins new contractOpen Orphan wins new contract
msn.com - September 28 at 11:20 PM
Swedens coronavirus deaths have dropped dramatically, but that doesnt mean its herd-immunity strategy worked, experts saySweden's coronavirus deaths have dropped dramatically, but that doesn't mean its herd-immunity strategy worked, experts say
businessinsider.com - September 23 at 10:32 PM
Selecta Biosciences/SOBI initiate late-stage study of SEL-212 for refractory goutSelecta Biosciences/SOBI initiate late-stage study of SEL-212 for refractory gout
seekingalpha.com - September 23 at 12:32 PM
Jupiter Orphan Announces Federal Grant to ADVANCE JOTROL™ to Phase I Clinical Trial for AlzheimersJupiter Orphan Announces Federal Grant to ADVANCE JOTROL™ to Phase I Clinical Trial for Alzheimer's
prnewswire.com - September 22 at 10:41 AM
Global Acquired Orphan Blood Diseases Therapeutics Market 2020 Strategic Market Growth, Key Manufacturers and Industry Demand Analysis to 2025Global Acquired Orphan Blood Diseases Therapeutics Market 2020 Strategic Market Growth, Key Manufacturers and Industry Demand Analysis to 2025
marketwatch.com - September 21 at 6:50 PM
Azelios energy storage technology shown to be significantly more sustainable than lithium-ion batteriesAzelio's energy storage technology shown to be significantly more sustainable than lithium-ion batteries
finance.yahoo.com - September 21 at 8:48 AM
Lipocine Announces Completion of Enrollment in the LPCN 1144 LiFT StudyLipocine Announces Completion of Enrollment in the LPCN 1144 LiFT Study
prnewswire.com - September 21 at 8:48 AM
First patient in treatment in RhoVacs clinical phase IIb study in SwedenFirst patient in treatment in RhoVac's clinical phase IIb study in Sweden
finance.yahoo.com - September 17 at 12:56 PM
Unpopular teens could be at higher risk of heart conditions later in life, study suggestsUnpopular teens could be at higher risk of heart conditions later in life, study suggests
msn.com - September 16 at 10:44 AM
Apples new smartwatch has a monitoring device that doctors credit with saving coronavirus patients lives. It can flag dangerous downturns.Apple's new smartwatch has a monitoring device that doctors credit with saving coronavirus patients' lives. It can flag dangerous downturns.
businessinsider.com - September 15 at 11:22 PM
Alzprotect Forges Ahead with First Patients Enrolled in Phase 2a Study in Progressive Supranuclear Palsy (PSP)Alzprotect Forges Ahead with First Patients Enrolled in Phase 2a Study in Progressive Supranuclear Palsy (PSP)
businesswire.com - September 14 at 7:08 AM
Anavex Life Sciences Announces Completion of ANAVEX(R)2-73 (blarcamesine) U.S. Phase 2 Rett Syndrome Clinical TrialAnavex Life Sciences Announces Completion of ANAVEX(R)2-73 (blarcamesine) U.S. Phase 2 Rett Syndrome Clinical Trial
marketwatch.com - September 10 at 8:34 AM
SELLAS Life gets green signal to initiate late-stage blood cancer study with GPS in FranceSELLAS Life gets green signal to initiate late-stage blood cancer study with GPS in France
seekingalpha.com - September 9 at 1:00 PM
European markets edge higher, shrugging off tech-led sell-off in the U.S.European markets edge higher, shrugging off tech-led sell-off in the U.S.
msn.com - September 9 at 1:00 PM
AstraZeneca COVID-19 vaccine study put on hold due to suspected adverse reaction in UK participantAstraZeneca COVID-19 vaccine study put on hold due to suspected adverse reaction in UK participant
foxnews.com - September 8 at 8:07 PM
The Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese PatentThe Daily Biotech Pulse: Sanofi, Regeneron Drop COVID-19 Study, 2 Positive AstraZeneca Catalysts, Brickell Awarded Japanese Patent
msn.com - September 1 at 9:23 AM
Plus Therapeutics rallies on Orphan Drug tag for glioblastoma treatmentPlus Therapeutics rallies on Orphan Drug tag for glioblastoma treatment
seekingalpha.com - September 1 at 9:23 AM
Swedish Steelmaker Uses Hydrogen Instead Of Coal To Make Fossil-Free SteelSwedish Steelmaker Uses Hydrogen Instead Of Coal To Make Fossil-Free Steel
forbes.com - September 1 at 12:33 AM
Galecto, Inc. Receives U.S. and EU Orphan Drug Designations for GB0139 in Idiopathic Pulmonary FibrosisGalecto, Inc. Receives U.S. and EU Orphan Drug Designations for GB0139 in Idiopathic Pulmonary Fibrosis
marketwatch.com - August 27 at 9:03 AM
Rare Inflammatory Disease Treatment Market Global Research and Clinical Analysis 2020 to 2026Rare Inflammatory Disease Treatment Market Global Research and Clinical Analysis 2020 to 2026
marketwatch.com - August 19 at 3:36 AM
Ascendis Dwarfism Candidate Gets Orphan Drug Status in EUAscendis' Dwarfism Candidate Gets Orphan Drug Status in EU
finance.yahoo.com - August 13 at 6:32 PM
Alzheimers blood test diagnosis moves closer to reality, scientists sayAlzheimer's blood test diagnosis moves closer to reality, scientists say
www.nbcnews.com - July 28 at 10:46 PM
Lillys P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimers Disease in Data Published in JAMALilly's P-tau217 Blood Test Shows High Accuracy in Diagnosis of Alzheimer's Disease in Data Published in JAMA
finance.yahoo.com - July 28 at 5:45 PM
Impact of Outbreak of COVID-19 on Orphan Drugs Market : Global Industry Analysis, Forecast 2025Impact of Outbreak of COVID-19 on Orphan Drugs Market : Global Industry Analysis, Forecast 2025
www.marketwatch.com - July 27 at 8:13 PM
Swedish Covid Policy Slammed by CEO at Front Line of CrisisSwedish Covid Policy Slammed by CEO at Front Line of Crisis
www.bloomberg.com - July 24 at 5:58 AM
This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.